E N D
Heart Failure: Definition A clinical syndrome that occurs in patients who, because of an inherited or acquired abnormality of cardiac structure or function, develop a constellation of clinical symptoms (dyspnea, fatigue) and signs (edema, rales), that lead to frequent hospitalizations, a poor quality of life, and a shortened life expectancy.
Heart Failure:A Progressive Disease, a Growing Burden 5 million Americans (2%) have HF Yearly incidence >500,000 cases/year 80% HF admissions are older than 65 1 million hospitalizations/year 5-10% of all admissions Most frequent reason for hospitalization in elderly 3000+ HF admissions in Maine 284,365 deaths in 2004 (28% increase over decade) More than lung, breast, prostate cancer and HIV/AIDS combined
Heart Failure:Risk Factors • Male gender • Older age • Physical inactivity • Obesity • Diabetes • Hypertension • Valvular heart disease • Cigarette smoking
Heart Failure:Etiologies • CAD 51% • Idiopathic 13% • Undetermined 10% • Valve 10% • Hypertension 6.4% • Other 5% • Alcohol 4% • Atrial Fibrillation 3% • Fox KF, Cowie MR, Wood DA, et al. Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J. 2001;22:228-236.
Heart Failure: Pathophysiology Volume overload Elevated left ventricular diastolic pressure Edema, jugular venous distension Dyspnea, hypoxia Elevated pulmonary arterial, venous pressure Renal salt, water retention
Heart Failure: Cardinal Symptoms • Dyspnea • Orthopnea • Edema • Cough • Liver engorgement
Heart Failure: Cardinal Signs • Tachycardia • Tachypnea • Hypoxia • Edema • Venous distension • Rales • Signs of pleural effusion (R>L) • Cardiac enlargement • Presystolic (S4) or protodiastolic (S3) gallop • Murmur? • Hepatomegaly/HJR
Heart Failure: Diagnosis • PE: signs of volume overload, LV dysfunction, valve disease • Imaging: 2DEcho with Doppler flow studies; CXR (?); ECG • Lab: CBC, chemistries, LFTs, TFTs, BNP (?) • Coronary angiography
Heart Failure: Differential Diagnosis • Infection • Neoplasm • Pulmonary embolism • Nephrotic syndrome • Venous insufficiency
Heart Failure Classification • A: At risk but asymptomatic, with no apparent structural abnormality (CAD, DM, ethanol use, family history…) • B: Asymptomatic but with cardiac structural abnormality (HTN/LVH, prior MI, valve disease) • C: Structural abnormality and symptoms • D: End stage, refractory HF
Heart Failure: Therapy • Stage A: • Control risk factors, treat underlying chronic disease contributors • Stage B: • ACE/ARB/BB if appropriate • Stage C: • ACE?ARB, BB, diuretics • Other vasodilators as appropriate • Devices (bi-V pacing, Implantable defibrillators • Stage D: • Mechanical assist devices • Continuous infusion of inotropics • Heart transplant • Hospice • Experimental surgery or drugs
Heart Failure: Prognosis 1950 - 2000 Framingham Heart Study